TRANSCODE THERAPEUTICS, INC.
  • About
  • Challenge
  • Diagnosis
  • Treatment
  • Delivery
  • Pipeline
  • Leadership
    • Management
    • Advisors
    • Contact
    • Investor Information
    • Reference Publications

TransCode Therapeutics

The Future of Cancer Treatment
Transforming the Diagnosis 
​and Treatment of Cancer 

Transforming the diagnosis and treatment of cancer

TransCode Therapeutics, Inc. is focused on the discovery, development and commercialization of a pipeline of innovative diagnostics and therapeutics for the detection and treatment of cancer, with an initial focus on metastasis. ​TransCode’s vision is to be the leader in Personalized Cancer Treatment employing data-driven cancer diagnostics as well as optimized targeted treatment solutions for each individual cancer patient that results in a significant improvement in their outcome.

Individualized Patient Approach

Picture

               Strategic Drivers

  • Significantly Improve Cancer Outcomes - Focus on Metastasis  
  • Data Driven - Translational Bioinformatics
  • Early Diagnostic Detection of Disease
  • Targeted Cancer Therapeutics​
​Conventional therapies aimed at treating primary cancer oftentimes are ineffective at treating metastatic cancer, resulting in poor outcomes in patients diagnosed with metastatic disease. ​

Improve Cancer Outcomes

Picture
  • Metastatic tumor cells are anatomically, biologically, and physiologically distinct from primary tumor cells
  • A need for differential treatment is paramount
  • Primary goal is to significantly improve treatment outcomes in patients with late stage disease
  • Combine data driven diagnostics with personalized treatment solutions to provide lasting regression of metastatic disease without recurrence
  • ​Treat individual patients based on mutation type, stage of disease and biomarker expression
  • Optimize dose and treatment duration for each individual patient

Data Driven 

Picture
  • Identify key biomarkers associated with primary and metastatic cancers
  • Apply highly specific biomarker diagnostic tools for cancer detection and staging
  • Assimilate biomarker expression data, stage of disease, tumor type, aggressiveness of disease etc.
  • Translational bioinformatics - data to inform therapeutic decision making and early intervention​

Early Detection 

Picture
​The staple of reducing mortality due to cancer has been early detection. 
  • Utilize novel diagnostic biomarkers for the presence of metastasis
  • Develop predictive biomarkers for early diagnosis of metastasis and disease progression
  • Identify patients at increased risk of progression
  • Stratify tumors based on aggressiveness to better inform treatment 

​Targeted Therapies

Picture
  • Therapeutic pipeline targeting metastasis
  • Treatment with lead-candidate therapeutic leads to durable regression/elimination of established metastases in murine models of metastatic breast cancer
  • Broad applicability across multiple tumor types
  • Image-guided treatment combines knowledge of drug bioavailability & outcome
  • Delivery-based therapeutic platform - backbone of therapeutic pipeline
  • Therapeutics targeting specific biomarkers in multiple cancer types
  • ​Combination therapies as a multipronged approach to treatment
Picture

Company

About
Challenge
​Diagnosis
Treatment
Delivery
​Pipeline

Leadership

Management Team
Advisory Board

Support

Contact
​Reference PUBLICATIONS
Investor INFORMATION
TERMS OF USE
PRIVACY POLICY
© TRANSCODE THERAPEUTICS, INC. 2019.​ ALL RIGHTS RESERVED.
  • About
  • Challenge
  • Diagnosis
  • Treatment
  • Delivery
  • Pipeline
  • Leadership
    • Management
    • Advisors
    • Contact
    • Investor Information
    • Reference Publications